BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30592989)

  • 1. High-sensitivity C-reactive protein and cystatin C independently and jointly predict all-cause mortality among the middle-aged and elderly Chinese population.
    Shen Y; Zhang Y; Xiong S; Zhu X; Ke C
    Clin Biochem; 2019 Mar; 65():7-14. PubMed ID: 30592989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint effect of elevated-c-reactive protein level and hypertension on new-onset stroke: A nationwide prospective cohort study of CHARLS.
    Chen X; Liu S; Chu J; Hu W; Sun N; Shen Y
    Front Public Health; 2022; 10():919506. PubMed ID: 36262245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of plasma albumin and hypersensitive C-reactive protein with 5-year all-cause mortality among Chinese older adults aged 65 and older from 8 longevity areas in China].
    Lyu YB; Zhou JH; Duan J; Wang JN; Shi WY; Yin ZX; Shi WH; Mao C; Shi XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Jun; 53(6):590-596. PubMed ID: 31177756
    [No Abstract]   [Full Text] [Related]  

  • 5. Baseline high-sensitivity C-reactive protein and glycosylated hemoglobinA1c predict adverse outcomes in patients with chronic coronary syndromes undergoing percutaneous coronary intervention.
    Tang XF; Yuan DS; Zhu P; Xu N; Yao Y; Wang PZ; Chen Y; Gao LJ; Song L; Yang YJ; Gao RL; Zhao XY; Yuan JQ
    Heliyon; 2024 Jan; 10(1):e23900. PubMed ID: 38192767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between high-sensitivity C-reactive protein and both cardiovascular, total mortality events in middle-aged Chinese adults].
    Dong Y; Wang ZW; Wang X; Tian Y; Zhang LF; Chen Z; Cao HQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Apr; 39(4):428-432. PubMed ID: 29699031
    [No Abstract]   [Full Text] [Related]  

  • 7. Cystatin C associates with the prediction of in-stent restenosis among patients receiving stent implantation: results of the 1-year follow-up.
    Zhao C; Yang L; Mao L; Zhong L; Li X; Wei S
    Coron Artery Dis; 2013 Aug; 24(5):357-60. PubMed ID: 23835667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography.
    Nead KT; Zhou MJ; Caceres RD; Sharp SJ; Wehner MR; Olin JW; Cooke JP; Leeper NJ
    Am J Cardiol; 2013 Mar; 111(6):851-6. PubMed ID: 23290308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations of serum cystatin C and hs-CRP with vascular endothelial cell injury in patients with systemic lupus erythematosus.
    Gao D; Shao J; Jin W; Xia X; Qu Y
    Panminerva Med; 2018 Dec; 60(4):151-155. PubMed ID: 29792017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for Prediction of Cardiovascular Events in Community-Dwelling Adults Aged 40 or Older.
    Chong Y; Ren Q; Li Y; Li C; Feng F; Zhou Y
    Int Heart J; 2020 Jan; 61(1):109-114. PubMed ID: 31875617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis.
    Li Y; Zhong X; Cheng G; Zhao C; Zhang L; Hong Y; Wan Q; He R; Wang Z
    Atherosclerosis; 2017 Apr; 259():75-82. PubMed ID: 28327451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent and joint effects of high-sensitivity c-reactive protein and hypoalbuminemia on long-term all-cause mortality among coronary artery disease: a prospective and multicenter cohort study.
    Huang H; Yu Y; Chen L; Chen S; Tang R; Li Q; Wei W; Bao K; Huang Z; Lai W; Wang B; Tan N; Chen J; Liu J; Liu Y
    BMC Cardiovasc Disord; 2021 Dec; 21(1):613. PubMed ID: 34961476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C levels are associated with the prognosis of systolic heart failure patients.
    Gao C; Zhong L; Gao Y; Li X; Zhang M; Wei S
    Arch Cardiovasc Dis; 2011 Nov; 104(11):565-71. PubMed ID: 22117908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The predictive value of the hs-CRP/HDL-C ratio, an inflammation-lipid composite marker, for cardiovascular disease in middle-aged and elderly people: evidence from a large national cohort study.
    Gao Y; Wang M; Wang R; Jiang J; Hu Y; Wang W; Wang Y; Li H
    Lipids Health Dis; 2024 Mar; 23(1):66. PubMed ID: 38429790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: findings from the 1999-2004 NHANES.
    Veeranna V; Zalawadiya SK; Panaich S; Patel KV; Afonso L
    Int J Cardiol; 2013 Oct; 168(6):5156-61. PubMed ID: 24016543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Synergic Association of hs-CRP and Serum Amyloid P Component in Predicting All-Cause Mortality in Patients With Type 2 Diabetes.
    Scarale MG; Copetti M; Garofolo M; Fontana A; Salvemini L; De Cosmo S; Lamacchia O; Penno G; Trischitta V; Menzaghi C
    Diabetes Care; 2020 May; 43(5):1025-1032. PubMed ID: 32144164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification of elderly patients with acute pulmonary embolism.
    Klingenberg R; Schlager O; Limacher A; Méan M; Vuilleumier N; Beer JH; Staub D; Frauchiger B; Aschwanden M; Lämmle B; Righini M; Egloff M; Osterwalder J; Angelillo-Scherrer A; Kucher N; Banyai M; Rodondi N; von Eckardstein A; Aujesky D; Husmann M; Matter CM
    Eur J Clin Invest; 2019 Sep; 49(9):e13154. PubMed ID: 31246275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystatin C is independently associated with total and cardiovascular mortality in individuals undergoing coronary angiography. The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
    Woitas RP; Kleber ME; Meinitzer A; Grammer TB; Silbernagel G; Pilz S; Tomaschitz A; Weihrauch G; Dobnig H; März W; Scharnagl H
    Atherosclerosis; 2013 Aug; 229(2):541-8. PubMed ID: 23706287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low High-Sensitivity C-Reactive Protein Level in Korean Patients With Chronic Kidney Disease and Its Predictive Significance for Cardiovascular Events, Mortality, and Adverse Kidney Outcomes: Results From KNOW-CKD.
    Lee C; Park KH; Joo YS; Nam KH; Chang TI; Kang EW; Lee J; Oh YK; Jung JY; Ahn C; Lee KB; Park JT; Yoo TH; Kang SW; Han SH
    J Am Heart Assoc; 2020 Nov; 9(21):e017980. PubMed ID: 33092438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of High-Sensitivity C-Reactive Protein and Its Relationship with Other Cardiovascular Risk Factors in the Middle-Aged Chinese Population.
    Wang Z; Wang X; Chen Z; Zhang L; Zhu M
    Int J Environ Res Public Health; 2016 Aug; 13(9):. PubMed ID: 27589783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.